SYBIL CHAMBERLAIN: Open Payments
NPI 1255963682 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 30 payments from 10 companies in 2025. Trend: 2023 $40 · 2024 $499 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $208 |
| Exact Sciences Corporation | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Medtronic, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $26 |
| Amgen Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: Ozempic, Cologuard Collection Kit, FARXIGA, Rybelsus, Wegovy, TZIELD, Kerendia, INCEPTIV.
Industry payments across TX — which companies pay providers there.
